Prepare for CMS's Hospital Harm Measures on Severe Hypo and Hyperglycemia

JANUARY 6, 2022 Karen Berger, PharmD Managing T1D in Adults: How Can Pharmacists Help? Type 1 diabetes requires patients to have knowledge and skill to manage medication and potential complications. Type 1 diabetes (T1D) is caused when the immune system destroys the insulin-producing β cells of the pancreas. T1D accounts for up to 10% of all cases of diabetes. Because

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management Leader in Endocrinology Research Implements eGlycemic Management System Across Hospitals, Dedicates Resources Towards Research and Development WALTHAM, Mass. (January 25, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska

Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside As CMS Creates an Emphasis on Hyperglycemia and Hypoglycemia Rates in the Hospital, Partnership Aims to Transform the Standard of Care WALTHAM, MASS. (January 12, 2022) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today

DECEMBER 1, 2021 By: Dr. Jordan Messler As CMS drives cost and quality improvements, here’s why glucose management is the newest focus The focus on glycemic management as a key indicator of patient safety was announced as part of CMS’s annual adjustment to inpatient payment policies, which are accompanied by updated rules for its Inpatient Quality Reporting (IQR) program. This

NOVEMBER 22, 2021 Jordan Messler, MD, SFHM, FACP Contributor: CMS Has Decided to Put Its Muscle Behind Glycemic Management—Why Now? CMS’ introduction of 3 new electronic clinical quality measures, 2 of which are focused on inpatient glycemic management, signal a strong commitment to shine a light on this often-overlooked area, according to the chief medical officer at Glytec. CMS recently

NOVEMBER 2021 By Derek Bagley Special Delivery: A Look at New Modes of Diabetes Care Thanks to insulin’s discovery a century ago, diabetes is no longer the death sentence it once was. However, providing care can often be complicated for both in- and outpatient treatment regimens. Potential new models of diabetes care could help ease the burden of both the

Glytec Awarded First Patient Safety Solutions Agreement with Premier Glytec named sole supplier of insulin management software for Premier’s network of more than 4,400 U.S. hospitals and 225,000 providers WALTHAM, MASS. (October 26, 2021) –Glytec – the only provider of cloud-based insulin management software across the continuum of care, today announced that it has been awarded a group purchasing agreement

SEPTEMBER 17 2021 By Nurse Keith The Promising Future of Cutting-Edge Diabetes Care | The Nurse Keith Show, EPS 341 On episode 341 of The Nurse Keith Show nursing and healthcare career podcast, Keith interviews Lori Weiss, a highly skilled and experienced nurse and Certified Diabetes and Care and Education Specialist (CDCES) with Glytec, a thriving company that has created

Healthcare Industry Leaders Unite Around Patient Safety at Glytec’s Inaugural Conference on Glycemic Innovation and Collaboration Conference Identifies Key Strategies and Actionable Insights for Hospitals to Optimize Glycemic Management Ahead of New CMS Core Measures WALTHAM, MASS. (August 31, 2021) – Glytec, the only provider of cloud-based insulin management software across the continuum of care, today revealed details about its